CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity
NVO's Wegovy pill gets CHMP backing, moving it closer to becoming the first oral GLP-1 treatment approved in the EU for weight management.
Open original sourceLoading market dashboard
NVO's Wegovy pill gets CHMP backing, moving it closer to becoming the first oral GLP-1 treatment approved in the EU for weight management.
Open original source